Qiming Venture Partners

Xi'an Dunbo Medical Equipment focuses on the research, development, and production of AI medical devices. The products currently under development are cardiac pacemakers and brain pacemakers, Cardiac defibrillators. Self-developed products include chips, hardware circuits, software application systems, and structural materials.

AusperBio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for hepatitis B and advancing oligonucleotide therapeutics. Utilizing its proprietary Med-Oligo™ ASO platform, AusperBio aims to deliver effective targeted therapies that leverage antisense oligonucleotide technology. The company is dedicated to transforming the treatment landscape for hepatitis B, with an emphasis on finding a cure and providing protection through novel therapeutic approaches. Additionally, AusperBio's research extends to addressing a variety of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, thereby broadening the potential impact of its therapeutic innovations.

Speediance focuses on the development of smart fitness equipment tailored for at-home strength training. The company offers innovative gym equipment that integrates an online platform, providing users with training guidance and instructional courses. This approach allows individuals to enhance their home workout experiences while connecting with a broader workout community. By combining advanced technology with fitness, Speediance aims to facilitate effective strength training for users in a self-service format.

Zhongyi Rehabilitation is a provider of rehabilitation products and services that focuses on the operation of chain rehabilitation centers to provide patients with one-stop professional rehabilitation needs and solutions.

Dr.Clear is an oral invisible orthodontic solution service provider that specializes in offering safe and comfortable digital solutions for face development management and invisible dental correction for children and adolescents.

LTZ Therapeutics specializes in the development of innovative immunotherapies aimed at treating patients with cancer and other diseases that currently lack effective treatment options. By employing reverse translational science and tumor biology in conjunction with machine learning, the company focuses on creating novel cancer therapies. This approach enables the identification and development of targeted treatments that address unmet clinical needs, ultimately improving patient outcomes in the field of oncology and beyond.

Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.

Dezhen Technology provides solutions for medical institutions to help hospitals develop clinical, and scientific research management. Dezhen Technology is headquartered in Hongkou, China.

CureGenetics is a biotechnology company focused on advancing innovative medicines and molecular diagnostics through the application of gene editing technologies. The company specializes in the research and development of solutions aimed at the treatment of cancers and genetic diseases. CureGenetics is dedicated to creating next-generation therapies that enhance patient outcomes by leveraging cutting-edge techniques in gene editing and delivery platforms. Through its efforts, the company aims to contribute significantly to the field of personalized medicine and improve treatment options for complex health conditions.

Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, specializes in developing advanced technologies for the early detection and treatment of cancer and other diseases. The company focuses on a precision proteomics platform that facilitates protein analysis and the creation of antibody technologies. This platform is designed to enhance the diagnosis of diseases, particularly cancer, while also supporting the discovery of new biomarkers. By enabling healthcare providers to detect diseases at an early stage, Alamar Biosciences aims to improve patient outcomes through timely interventions and potential cures.

Dr.Clear is an oral invisible orthodontic solution service provider that specializes in offering safe and comfortable digital solutions for face development management and invisible dental correction for children and adolescents.

ACXEL Tech specializes in developing advanced large-area electronics that enable innovative applications in drug discovery and biological research. The company's proprietary digital microfluidic platform utilizes millions of 'active' pixels to manipulate liquid droplets with high precision and speed. This technology serves as a programmable and cost-effective solution for various applications, including fundamental bio-related research, cell line development, cell therapy, synthetic biology, and antibody therapy. By allowing clients to conduct complex experimental procedures at the single-cell level, ACXEL enhances productivity and efficiency within the fields of chemistry, biology, and medtech.

Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.

LTZ Therapeutics specializes in the development of innovative immunotherapies aimed at treating patients with cancer and other diseases that currently lack effective treatment options. By employing reverse translational science and tumor biology in conjunction with machine learning, the company focuses on creating novel cancer therapies. This approach enables the identification and development of targeted treatments that address unmet clinical needs, ultimately improving patient outcomes in the field of oncology and beyond.

CuroVax, established in 2011 and headquartered in Changzhou City, China, specializes in vaccine development and production. The company offers a range of vaccines, including a freeze-dried rabies vaccine for human use and an influenza virus split vaccine. CuroVax employs a dual approach of independent development and collaborative research, supported by multiple technology platforms such as large-scale mammalian cell culture and mRNA vaccine development. It provides biotechnology and microbiology services, focusing on improving health and medical industry standards.

Complete Omics is a company focused on the development of multi-omics diagnostics for early disease detection, particularly in cancer. The firm specializes in creating personalized diagnosis and treatment platforms that leverage advanced technologies across various omics fields. With patented innovations, Complete Omics offers precision companion diagnostics that enhance the ability to conduct sensitive and specific health surveillance tests. By enabling researchers and pharmaceutical companies to utilize these sophisticated tools, Complete Omics aims to improve diagnosis and treatment outcomes in the field of oncology.

Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

1 Yong Cloud is a Beijing-based company founded in 2017 that specializes in developing and operating a tumor diagnosis and treatment standardization platform. The platform is designed to assist healthcare professionals in formulating personalized diagnosis and treatment plans for patients with tumor diseases. By collecting and translating medical data, 1 Yong Cloud aims to enhance the quality and standardization of medical practices while rationalizing treatment expenses. Through its comprehensive data and system services, the company supports physicians in making informed decisions to improve patient outcomes.

Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.

Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Sunny Dental, founded in 2007 and based in Beijing, China, specializes in a comprehensive range of orthodontic services. The company provides diagnosis and treatment for dental implants, children’s dentistry, dental restorations, periodontal disease, dental pulp issues, and oral and maxillofacial surgery. Sunny Dental is dedicated to offering professional care and advanced solutions in various aspects of dental health, ensuring a focus on both preventative and restorative treatments.

PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.

Core Medical (Beijing) Co., Ltd. is a contract research organization (CRO) founded in 2013 and based in Beijing, China. The company specializes in clinical professional services focused on new technologies and innovative products within the cardiovascular sector. Core Medical offers a range of services, including animal testing, type testing, First-in-Man (FIM) studies, human studies, and statistics and data management for clinical research. By providing these services, Core Medical helps companies in the cardiovascular field evaluate and validate their products, facilitating advancements in medical technology.

Thorough Future specializes in incorporating advanced technology into medical care, focusing on improving diagnostic services in clinical medicine. The company develops artificial intelligence solutions to enhance pathology image diagnosis, utilizing big data and AI to deliver intelligent diagnostic and predictive services. By doing so, Thorough Future aims to increase the efficiency of diagnoses and offer personalized treatment recommendations, particularly for cancer patients, thus contributing to improved patient outcomes in healthcare.

Intellinosis is a diagnostic company that focuses on developing molecular diagnostic reagents. Intellinosis is headquartered in Minhang District, China.

Dezhen Technology provides solutions for medical institutions to help hospitals develop clinical, and scientific research management. Dezhen Technology is headquartered in Hongkou, China.

Gaugene is a high-tech enterprise that specializes in the development and supply of hematology testing instruments, reagents, and services tailored for in vitro diagnostic (IVD) users. The company offers advanced instruments and reagents that play a critical role in hematology diagnosis, as well as broader clinical diagnostics and life science research. Gaugene is notable for being the only manufacturer in China that incorporates high-power flow lasers and high-sensitivity multi-color fluorescence detection systems in its products. This technological edge enables the company to provide innovative solutions for clinical diagnosis, flow cytometry technology, single cell research, protein screening, and the discovery of new clinical indicators. Gaugene is co-sponsored by experienced professionals from renowned domestic IVD companies, ensuring a strong foundation in industry-leading technologies.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

M20 Genomics is a life science and technology company focused on advancing single-cell sequencing technology and its applications. The company aims to establish itself as a global leader in next-generation single-cell technology for disease diagnosis and treatment. Its innovative single-cell sequencing platform is capable of detecting nearly 10,000 genes from individual cells or nuclei in various sample types, including fresh, frozen, and formalin-fixed paraffin-embedded specimens. This technology enables researchers to enhance the efficiency of their studies, particularly in bacterial research, by providing comprehensive data through full-length RNA sequencing.

Wanzhong Yixin Biotechnology is a developer of semiconductor integrated circuit biosensor chips and other related devices. The company's biosensor chip products are used in emerging fields such as genetic testing, water quality monitoring, and environmental protection IoT monitoring.

LTZ Therapeutics specializes in the development of innovative immunotherapies aimed at treating patients with cancer and other diseases that currently lack effective treatment options. By employing reverse translational science and tumor biology in conjunction with machine learning, the company focuses on creating novel cancer therapies. This approach enables the identification and development of targeted treatments that address unmet clinical needs, ultimately improving patient outcomes in the field of oncology and beyond.

ACXEL Tech specializes in developing advanced large-area electronics that enable innovative applications in drug discovery and biological research. The company's proprietary digital microfluidic platform utilizes millions of 'active' pixels to manipulate liquid droplets with high precision and speed. This technology serves as a programmable and cost-effective solution for various applications, including fundamental bio-related research, cell line development, cell therapy, synthetic biology, and antibody therapy. By allowing clients to conduct complex experimental procedures at the single-cell level, ACXEL enhances productivity and efficiency within the fields of chemistry, biology, and medtech.

Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.

CureGenetics is a biotechnology company focused on advancing innovative medicines and molecular diagnostics through the application of gene editing technologies. The company specializes in the research and development of solutions aimed at the treatment of cancers and genetic diseases. CureGenetics is dedicated to creating next-generation therapies that enhance patient outcomes by leveraging cutting-edge techniques in gene editing and delivery platforms. Through its efforts, the company aims to contribute significantly to the field of personalized medicine and improve treatment options for complex health conditions.

Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.

GenLight Medical is a company based in Hangzhou, China, that specializes in developing innovative treatment solutions for epilepsy and other neurological disorders. The firm focuses on creating advanced laser medical equipment and technologies aimed at improving patient outcomes in the fields of brain science and neurosurgery. Among its notable advancements are brain-computer control technology, full-cranial implantation techniques for deep brain nerve stimulation, brain computer chips, and systems for magnetic resonance guided laser ablation, which facilitate minimally invasive surgical procedures. GenLight Medical is committed to providing high-end, technologically advanced solutions for patients requiring brain surgery.

ShanZhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups, personalized health management plans, and insurance options. Additionally, it offers medical examination services and data finance products aimed at mitigating the challenges posed by an aging population and the rising prevalence of chronic diseases. Through its comprehensive services, ShanZhen seeks to enhance the quality of life for elderly patients, promoting healthier and happier living conditions.

Genevide is a biotech company established in 2019 and based in Suzhou, Jiangsu, China. The company focuses on gene research and development, specifically addressing challenges in nucleic acid detection. Genevide has developed a molecular enzyme cycle screening platform that includes enzyme-mediated one-step sample processing technology and enzyme-mediated double exponential amplification nucleic acid detection technology. These innovations aim to enhance the accessibility and efficiency of nucleic acid detection for researchers.

Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, specializes in developing advanced technologies for the early detection and treatment of cancer and other diseases. The company focuses on a precision proteomics platform that facilitates protein analysis and the creation of antibody technologies. This platform is designed to enhance the diagnosis of diseases, particularly cancer, while also supporting the discovery of new biomarkers. By enabling healthcare providers to detect diseases at an early stage, Alamar Biosciences aims to improve patient outcomes through timely interventions and potential cures.

HilleVax is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, founded in 2021. The company specializes in the development and commercialization of innovative vaccines. Its primary focus is on HIL-214, a virus-like particle (VLP) based vaccine candidate aimed at preventing moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. HilleVax is dedicated to addressing significant public health challenges through its vaccine initiatives.

Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.

PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.

Zuoshouyisheng's AI ​​doctor platform spans 35 medical specialties and can diagnose more than 6,000 diseases, according to the company’s website. Zuoshouyisheng mainly collaborates with customers through a SaaS business model, providing its AI-empowered healthcare system to hospitals, pharmaceutical companies, employers, and insurers.

Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.

Health Biotech is a research and development firm focused on precision medicine through the application of mass spectrometry technology. The company specializes in creating comprehensive detection solutions that include tools, equipment, and reagent consumables. Its innovative technology employs liquid chromatography-mass spectrometry to facilitate the early diagnosis, treatment, and monitoring of Alzheimer's disease. By quantitatively detecting specific biomarkers, such as "ipilin," Health Biotech enables healthcare professionals to assess Alzheimer's risk and provide targeted interventions aimed at delaying disease onset and enhancing cognitive function in patients. Through its commitment to advancing mass spectrometry applications, Health Biotech strives to deliver reliable services and improve patient outcomes in the realm of neurological health.

Just Medical is a developer and manufacturer of artificial orthopedic implant devices and systems, specializing in products such as artificial hip and knee joints, internal fixation products, and orthopedic surgical instruments. The company is dedicated to enhancing surgical efficiency and improving the quality of orthopedic treatment through advanced technology research and development. Just Medical focuses on creating safe and effective medical products and services, continually refining its product system to address the needs of healthcare providers and alleviate patient pain. Its commitment to high-speed development and excellence positions it as a key player in the orthopedic medical device industry.

Gaugene is a high-tech enterprise that specializes in the development and supply of hematology testing instruments, reagents, and services tailored for in vitro diagnostic (IVD) users. The company offers advanced instruments and reagents that play a critical role in hematology diagnosis, as well as broader clinical diagnostics and life science research. Gaugene is notable for being the only manufacturer in China that incorporates high-power flow lasers and high-sensitivity multi-color fluorescence detection systems in its products. This technological edge enables the company to provide innovative solutions for clinical diagnosis, flow cytometry technology, single cell research, protein screening, and the discovery of new clinical indicators. Gaugene is co-sponsored by experienced professionals from renowned domestic IVD companies, ensuring a strong foundation in industry-leading technologies.

ET Healthcare, Inc. is an in vitro diagnostics company specializing in the development and manufacturing of central laboratory analyzers designed for both inpatient and outpatient testing across various medical settings, including hospitals and clinics. The company's flagship product, the Pylon Immunochemistry System, integrates a central laboratory analyzer tailored for point-of-care testing, addressing diverse immunodiagnostic needs such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, ET Healthcare offers the Pylon BNP Immunoassay, which aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. With a focus on improving diagnostic efficiency and reducing the complexity of testing environments, the company aims to provide high-sensitivity tests while minimizing space and resource requirements. Headquartered in Palo Alto, California, ET Healthcare also operates offices in Shanghai, China, and has manufacturing facilities in Suzhou, China.

MEDx is a company specializing in precision medicine solutions aimed at enhancing clinical development. Founded in 2013 and headquartered in Suzhou, Jiangsu, MEDx employs translational science to advance diagnostic technologies related to nucleic acids and proteins. Its comprehensive services include biomarker development, Companion Diagnostics, Point-of-Care development, clinical testing, and the commercialization of medical products. By focusing on individualized treatment, MEDx seeks to improve patient outcomes through its innovative approaches in the healthcare sector.

Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, specializes in developing advanced technologies for the early detection and treatment of cancer and other diseases. The company focuses on a precision proteomics platform that facilitates protein analysis and the creation of antibody technologies. This platform is designed to enhance the diagnosis of diseases, particularly cancer, while also supporting the discovery of new biomarkers. By enabling healthcare providers to detect diseases at an early stage, Alamar Biosciences aims to improve patient outcomes through timely interventions and potential cures.

Bioscience provides in vitro diagnostic medical devices and reagents intended to enhance the diagnostic capabilities of healthcare professionals. They offer products that include chemiluminescence, point-of-care testing, and supporting instruments and reagents that enable healthcare organizations to offer enhanced care.

CureGenetics is a biotechnology company focused on advancing innovative medicines and molecular diagnostics through the application of gene editing technologies. The company specializes in the research and development of solutions aimed at the treatment of cancers and genetic diseases. CureGenetics is dedicated to creating next-generation therapies that enhance patient outcomes by leveraging cutting-edge techniques in gene editing and delivery platforms. Through its efforts, the company aims to contribute significantly to the field of personalized medicine and improve treatment options for complex health conditions.

Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

Berry Genomics is a biotechnology company focused on the development and commercialization of genomic technologies for life sciences and clinical applications. The company specializes in next generation sequencing (NGS) tests aimed at detecting genetic diseases and cancers throughout various life stages, from preconception to adulthood. In addition to its testing services, Berry Genomics offers gene sequencing detection equipment, contributing to advancements in genetic research and diagnostics. Through its innovative approach, the company plays a significant role in the evolving field of genomics.

Element Science, Inc. is a medical device and digital health company focused on developing innovative solutions for high-risk cardiovascular patients. Founded in 2011 and headquartered in San Francisco, California, the company specializes in a patch-based wearable cardioverter defibrillator (WCD) designed to monitor patients' heart activity and mitigate the risks associated with sudden cardiac death. Element Science integrates advanced machine learning algorithms with human-centered design principles and stringent electromechanical medical device standards to create a proprietary wearable digital platform. This platform aims to provide continuous protection for patients with heart disease, addressing critical health needs as they transition from hospital care to daily life.

Sunny Dental, founded in 2007 and based in Beijing, China, specializes in a comprehensive range of orthodontic services. The company provides diagnosis and treatment for dental implants, children’s dentistry, dental restorations, periodontal disease, dental pulp issues, and oral and maxillofacial surgery. Sunny Dental is dedicated to offering professional care and advanced solutions in various aspects of dental health, ensuring a focus on both preventative and restorative treatments.

Shenzhen Tisenc Medical Devices Co., Ltd., established in 2015, is a Sino-foreign joint venture based in Shenzhen, Guangdong. The company specializes in the development, manufacturing, and global sales of chemiluminescence immunology systems and advanced diagnostic solutions. Tisenc focuses on creating automatic chemiluminescent analyzers and supporting diagnostic reagents, which are essential in the field of medical diagnostics and point-of-care testing. With over 16,000 square meters dedicated to research and development labs, a GMP factory, and an instrument manufacturing facility, Tisenc maintains full intellectual property rights for its products and technologies, ensuring independence in its research and production processes.

ShanZhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups, personalized health management plans, and insurance options. Additionally, it offers medical examination services and data finance products aimed at mitigating the challenges posed by an aging population and the rising prevalence of chronic diseases. Through its comprehensive services, ShanZhen seeks to enhance the quality of life for elderly patients, promoting healthier and happier living conditions.

MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.

APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.

ZD Medical is a developer of advanced medical imaging technology focused on improving the diagnosis and treatment of retinal conditions. The company specializes in phase variance optical coherence tomography, a non-invasive tool that enables the simultaneous detection of macular degeneration and retinal microvascular proliferation related to diabetes. This innovative approach provides healthcare professionals with essential insights for the early identification of diabetic retinopathy. ZD Medical combines expertise from both domestic and international scientific and technological professionals to design and manufacture high-quality medical devices. The organization is committed to delivering effective solutions for medical diagnosis and clinical treatment, ultimately aiming to enhance healthcare outcomes and contribute positively to global health initiatives.

APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.

ET Healthcare, Inc. is an in vitro diagnostics company specializing in the development and manufacturing of central laboratory analyzers designed for both inpatient and outpatient testing across various medical settings, including hospitals and clinics. The company's flagship product, the Pylon Immunochemistry System, integrates a central laboratory analyzer tailored for point-of-care testing, addressing diverse immunodiagnostic needs such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, ET Healthcare offers the Pylon BNP Immunoassay, which aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. With a focus on improving diagnostic efficiency and reducing the complexity of testing environments, the company aims to provide high-sensitivity tests while minimizing space and resource requirements. Headquartered in Palo Alto, California, ET Healthcare also operates offices in Shanghai, China, and has manufacturing facilities in Suzhou, China.

CureGenetics is a biotechnology company focused on advancing innovative medicines and molecular diagnostics through the application of gene editing technologies. The company specializes in the research and development of solutions aimed at the treatment of cancers and genetic diseases. CureGenetics is dedicated to creating next-generation therapies that enhance patient outcomes by leveraging cutting-edge techniques in gene editing and delivery platforms. Through its efforts, the company aims to contribute significantly to the field of personalized medicine and improve treatment options for complex health conditions.

APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.

CANbridge Pharma is a biopharmaceutical company focused on the development and commercialization of healthcare products in China and North Asia, particularly for oncology and rare diseases. Established in 2012 and headquartered in Beijing, with additional offices in Shanghai, Cambridge, Taipei, and Hong Kong, the company partners with Western biopharmaceutical firms to bring clinical-stage pharmaceutical, medical device, and diagnostic products to the region. CANbridge specializes in therapies for serious medical conditions that are either unavailable or inadequately addressed in North Asia. Its key product, CAN008, is a glycosylated CD95-Fc fusion protein aimed at treating glioblastoma multiforme, while the company also has a diverse pipeline of biologics and small molecules targeting conditions such as Hunter Syndrome, hemophilia A, and various rare metabolic disorders. Through licensing and exclusive commercialization agreements, CANbridge seeks to enhance healthcare solutions for underserved patient populations in the region.

Core Medical (Beijing) Co., Ltd. is a contract research organization (CRO) founded in 2013 and based in Beijing, China. The company specializes in clinical professional services focused on new technologies and innovative products within the cardiovascular sector. Core Medical offers a range of services, including animal testing, type testing, First-in-Man (FIM) studies, human studies, and statistics and data management for clinical research. By providing these services, Core Medical helps companies in the cardiovascular field evaluate and validate their products, facilitating advancements in medical technology.

Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.

Sino Biological Inc. is an international provider of biological solutions, specializing in the research and development of recombinant proteins and monoclonal antibodies. Established in 2007 and headquartered in Beijing, China, the company offers a wide range of products, including cDNA clones, qPCR primers, ELISA kits, purification resins, transfection reagents, and enzyme tools. These products support research in immunology, oncology, cell biology, neuroscience, and stem cells, and can be instrumental in treating various diseases such as lung cancer, lymphoma, and arthritis. Sino Biological also provides contract research services and gene cloning, catering to universities, hospitals, pharmaceutical and biotechnology firms, and research institutions. With advanced platform technologies, the company delivers high-quality results and products efficiently, enabling clients to enhance their research and development capabilities. Its innovative solutions are recognized by several leading international pharmaceutical companies, bolstering drug discovery and biological research efforts.

Shenzhen Tisenc Medical Devices Co., Ltd., established in 2015, is a Sino-foreign joint venture based in Shenzhen, Guangdong. The company specializes in the development, manufacturing, and global sales of chemiluminescence immunology systems and advanced diagnostic solutions. Tisenc focuses on creating automatic chemiluminescent analyzers and supporting diagnostic reagents, which are essential in the field of medical diagnostics and point-of-care testing. With over 16,000 square meters dedicated to research and development labs, a GMP factory, and an instrument manufacturing facility, Tisenc maintains full intellectual property rights for its products and technologies, ensuring independence in its research and production processes.

The Chain Medical Labs is a professional independent medical laboratory established from a team of experienced technical and management experts which is one of the Shanghai Chain medical investment management Inc. also alliance with few internationally renowned lab and vendors. The company utilize advanced testing methods, quality management systems, automation technology as Europe, America and Japan for their Clinical Diagnostics. CMLabs features in clinical laboratory services, clinical trial services, research services, and laboratory information system services to support all medical institutions, as well as assist to obtain ISO15189 certification, CAP accreditation (United States Association of pathology quality system), SOP process and external audit services.

ZD Medical is a developer of advanced medical imaging technology focused on improving the diagnosis and treatment of retinal conditions. The company specializes in phase variance optical coherence tomography, a non-invasive tool that enables the simultaneous detection of macular degeneration and retinal microvascular proliferation related to diabetes. This innovative approach provides healthcare professionals with essential insights for the early identification of diabetic retinopathy. ZD Medical combines expertise from both domestic and international scientific and technological professionals to design and manufacture high-quality medical devices. The organization is committed to delivering effective solutions for medical diagnosis and clinical treatment, ultimately aiming to enhance healthcare outcomes and contribute positively to global health initiatives.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

Berry Genomics is a biotechnology company focused on the development and commercialization of genomic technologies for life sciences and clinical applications. The company specializes in next generation sequencing (NGS) tests aimed at detecting genetic diseases and cancers throughout various life stages, from preconception to adulthood. In addition to its testing services, Berry Genomics offers gene sequencing detection equipment, contributing to advancements in genetic research and diagnostics. Through its innovative approach, the company plays a significant role in the evolving field of genomics.

Bioscience provides in vitro diagnostic medical devices and reagents intended to enhance the diagnostic capabilities of healthcare professionals. They offer products that include chemiluminescence, point-of-care testing, and supporting instruments and reagents that enable healthcare organizations to offer enhanced care.

Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

VR Medical, established in 2009, is a US-based company that specializes in providing comprehensive manufacturing solutions for medical device companies and distributors. The company focuses on offering a single-sourced solution for new product development, outsourcing, contract manufacturing, and secure product distribution within China. VR Medical's unique capabilities include the development and low-cost manufacturing of disposable products and electronic devices, catering to private labels, OEMs, and distributors globally. Their medical devices are designed to support various medical markets, including respiratory care, critical care, blood purification, and advanced wound care.

Sino Biological Inc. is an international provider of biological solutions, specializing in the research and development of recombinant proteins and monoclonal antibodies. Established in 2007 and headquartered in Beijing, China, the company offers a wide range of products, including cDNA clones, qPCR primers, ELISA kits, purification resins, transfection reagents, and enzyme tools. These products support research in immunology, oncology, cell biology, neuroscience, and stem cells, and can be instrumental in treating various diseases such as lung cancer, lymphoma, and arthritis. Sino Biological also provides contract research services and gene cloning, catering to universities, hospitals, pharmaceutical and biotechnology firms, and research institutions. With advanced platform technologies, the company delivers high-quality results and products efficiently, enabling clients to enhance their research and development capabilities. Its innovative solutions are recognized by several leading international pharmaceutical companies, bolstering drug discovery and biological research efforts.

MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.

CANbridge Pharma is a biopharmaceutical company focused on the development and commercialization of healthcare products in China and North Asia, particularly for oncology and rare diseases. Established in 2012 and headquartered in Beijing, with additional offices in Shanghai, Cambridge, Taipei, and Hong Kong, the company partners with Western biopharmaceutical firms to bring clinical-stage pharmaceutical, medical device, and diagnostic products to the region. CANbridge specializes in therapies for serious medical conditions that are either unavailable or inadequately addressed in North Asia. Its key product, CAN008, is a glycosylated CD95-Fc fusion protein aimed at treating glioblastoma multiforme, while the company also has a diverse pipeline of biologics and small molecules targeting conditions such as Hunter Syndrome, hemophilia A, and various rare metabolic disorders. Through licensing and exclusive commercialization agreements, CANbridge seeks to enhance healthcare solutions for underserved patient populations in the region.

Twine Health, Inc. is a cloud-based software platform focused on chronic care management. Founded in 2012 and based in Cambridge, Massachusetts, Twine Health provides tools for shared decision-making, enabling patients and clinicians to collaboratively set health goals and evaluate management options. Its platform includes self-tracking tools that empower patients to take control of their conditions, dashboards for clinicians to monitor patient progress, and integrated messaging features to facilitate communication. Twine Health also offers a patient engagement portal, a peer support network, and an outcome analytics tool, all designed to foster collaboration among patients, healthcare providers, and support teams such as nurses and health coaches. The platform aims to enhance patient self-efficacy and improve health outcomes through continuous, personalized care.

ET Healthcare, Inc. is an in vitro diagnostics company specializing in the development and manufacturing of central laboratory analyzers designed for both inpatient and outpatient testing across various medical settings, including hospitals and clinics. The company's flagship product, the Pylon Immunochemistry System, integrates a central laboratory analyzer tailored for point-of-care testing, addressing diverse immunodiagnostic needs such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, ET Healthcare offers the Pylon BNP Immunoassay, which aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. With a focus on improving diagnostic efficiency and reducing the complexity of testing environments, the company aims to provide high-sensitivity tests while minimizing space and resource requirements. Headquartered in Palo Alto, California, ET Healthcare also operates offices in Shanghai, China, and has manufacturing facilities in Suzhou, China.

ZappRx is a digital health company based in Boston, Massachusetts, founded in 2012. It specializes in providing a cloud-based platform that streamlines the process of ordering specialty medications for healthcare providers, specialty pharmacies, and biopharma companies. The platform facilitates secure digital interactions among providers, pharmacists, and payers, reducing reliance on traditional methods like faxes and phone calls. By automating prescription management and prior authorization processes, ZappRx enhances efficiency in collecting and maintaining necessary information for specialty prescribing. This includes details such as pharmacy information, payer requirements, and clinical history. The company's platform is utilized across various medical fields, including pulmonary, cardiology, and gastroenterology.

CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

Berry Genomics is a biotechnology company focused on the development and commercialization of genomic technologies for life sciences and clinical applications. The company specializes in next generation sequencing (NGS) tests aimed at detecting genetic diseases and cancers throughout various life stages, from preconception to adulthood. In addition to its testing services, Berry Genomics offers gene sequencing detection equipment, contributing to advancements in genetic research and diagnostics. Through its innovative approach, the company plays a significant role in the evolving field of genomics.

APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.

VINNO Technology, founded in 2010 in Suzhou Industrial Park, specializes in the development and manufacture of high-end color Doppler ultrasound diagnostic systems. With a focus on innovation, the company produces a range of ultrasound equipment, including consoles and portable imaging tools, aimed at enhancing diagnostic processes in hospitals and clinics. By providing accessible medical solutions, VINNO enables healthcare professionals to deliver more accurate and efficient diagnoses and treatments for patients. The company is based in China and actively seeks partnerships globally to expand its reach and bring advanced medical technology to a wider audience.

The Chain Medical Labs is a professional independent medical laboratory established from a team of experienced technical and management experts which is one of the Shanghai Chain medical investment management Inc. also alliance with few internationally renowned lab and vendors. The company utilize advanced testing methods, quality management systems, automation technology as Europe, America and Japan for their Clinical Diagnostics. CMLabs features in clinical laboratory services, clinical trial services, research services, and laboratory information system services to support all medical institutions, as well as assist to obtain ISO15189 certification, CAP accreditation (United States Association of pathology quality system), SOP process and external audit services.

CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

Shanghai Rendu Biotechnology Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2007. The company specializes in the development and promotion of real-time fluorescence thermostatic expansion technology and simultaneous amplification and testing (SAT) technology. These innovations are applied across various domains, including reproductive health services, respiratory disease treatment, and intestinal microorganism services. Shanghai Rendu Biotechnology is recognized for its focus on RNA-based diagnostic technologies, positioning itself as a high-tech firm in the biotechnology sector.

ET Healthcare, Inc. is an in vitro diagnostics company specializing in the development and manufacturing of central laboratory analyzers designed for both inpatient and outpatient testing across various medical settings, including hospitals and clinics. The company's flagship product, the Pylon Immunochemistry System, integrates a central laboratory analyzer tailored for point-of-care testing, addressing diverse immunodiagnostic needs such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, ET Healthcare offers the Pylon BNP Immunoassay, which aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. With a focus on improving diagnostic efficiency and reducing the complexity of testing environments, the company aims to provide high-sensitivity tests while minimizing space and resource requirements. Headquartered in Palo Alto, California, ET Healthcare also operates offices in Shanghai, China, and has manufacturing facilities in Suzhou, China.

CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.

CANbridge Pharma is a biopharmaceutical company focused on the development and commercialization of healthcare products in China and North Asia, particularly for oncology and rare diseases. Established in 2012 and headquartered in Beijing, with additional offices in Shanghai, Cambridge, Taipei, and Hong Kong, the company partners with Western biopharmaceutical firms to bring clinical-stage pharmaceutical, medical device, and diagnostic products to the region. CANbridge specializes in therapies for serious medical conditions that are either unavailable or inadequately addressed in North Asia. Its key product, CAN008, is a glycosylated CD95-Fc fusion protein aimed at treating glioblastoma multiforme, while the company also has a diverse pipeline of biologics and small molecules targeting conditions such as Hunter Syndrome, hemophilia A, and various rare metabolic disorders. Through licensing and exclusive commercialization agreements, CANbridge seeks to enhance healthcare solutions for underserved patient populations in the region.

JFK Biotech develops products for molecular diagnosis and rapid self-test technology. They also offer a series of products for early screening, early diagnosis, and early treatment of pulmonary nodules, lung cancer, COPD, asthma, airway inflammation, and airway infection.